Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, . . . Ersilia Lucenteforte. (2023). Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. MDPI AG.
Chicago Style (17th ed.) CitationIrma Convertino, et al. Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. MDPI AG, 2023.
MLA (9th ed.) CitationIrma Convertino, et al. Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.